Nucleus Soft.

Why is Nucleus Software Exports Ltd falling/rising?

As of 02-Sep, Nucleus Software Exports Ltd is experiencing a slight rise in stock price, attributed to short-term positive trends and increased investor participation. However, the company faces significant long-term challenges, including a year-to-date decline of 18.97% and negative quarterly results.

As of 02-Sep, Nucleus Software Exports Ltd is experiencing a slight rise in its stock price, currently at 741.00, with a change of 0.95 (0.13%) upward. This increase can be attributed to several factors. Firstly, the stock has outperformed its sector today by 1.67%, indicating a positive trend in the short term. Additionally, there has been a trend reversal as the stock gained after two consecutive days of decline, suggesting a potential recovery phase.<BR><BR>Investor participation has also increased, with a notable rise in delivery volume by 67.72% compared to the 5-day average, which reflects growing interest among investors. Furthermore, the stock is currently trading above its 5-day, 20-day, and 50-day moving averages, although it remains below its 100-day and 200-day moving averages. This positioning may indicate a short-term bullish sentiment.<BR><BR>Despite these positive indicators, it is important to note that the stock has faced significant challenges over the longer term, with a year-to-date decline of 18.97% and a one-year drop of 27.90%. The company has reported negative results for the last four consecutive quarters, and its profits have fallen by 30.9%. Additionally, institutional investors have decreased their stake, which may reflect a lack of confidence in the company's long-term growth prospects.<BR><BR>In summary, while Nucleus Software Exports Ltd is currently rising due to short-term positive performance and increased investor participation, it faces substantial long-term challenges that could impact its future stock performance.

Which are the latest news on Nucleus Soft.?

Who are in the management team of Nucleus Soft.?

The management team of Nucleus Soft includes Vishnu R Dusad (Managing Director), R P Singh (Executive Director & CEO), Parag Bhise (Whole Time Director & CEO), and several independent directors, among others, who guide the company's governance and strategy.

The management team of Nucleus Soft includes the following individuals:<BR><BR>1. **Vishnu R Dusad** - Managing Director<BR>2. **Prithvi Haldea** - Independent Director<BR>3. **Poonam Bhasin** - Company Secretary & Compliance Officer<BR>4. **Trilochan Sastry** - Independent Director<BR>5. **R P Singh** - Executive Director & CEO<BR>6. **Elaine Mathias** - Independent Director<BR>7. **S M Acharya** - Chairman & Independent Director<BR>8. **Ritika Dusad** - Director<BR>9. **Parag Bhise** - Whole Time Director & CEO<BR>10. **Anurag Mantri** - Executive Director & CFO<BR>11. **Yasmin Javeri Krishan** - Independent Director<BR><BR>This diverse team plays a crucial role in the company's governance and strategic direction.

What does Nucleus Soft. do?

Nucleus Software Exports Ltd is a global provider of enterprise lending and transaction banking solutions, classified as a Small Cap company with a market cap of INR 1,947 Cr. As of June 2026, it reported net sales of 210 Cr and a net profit of 24 Cr.

Overview: <BR>Nucleus Software Exports Ltd is a global provider of enterprise lending and transaction banking solutions, operating within the Software Products industry and classified as a Small Cap company.<BR><BR>History: <BR>Nucleus Software Exports Ltd was incorporated on 9th January 1989 as a Private Limited Company and was converted into a Public Limited Company on 10 October 1994. The company made an Initial Public Offer in August 1995. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 210 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 24 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 1,947 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 17.00 <BR>Industry P/E: 22 <BR>Dividend Yield: 1.71% <BR>Debt Equity: -0.45 <BR>Return on Equity: 14.89% <BR>Price to Book: 2.16 <BR><BR>Contact Details: <BR>Address: 33-35 Thyagraj Nagar Market, Near Lodhi Colony New Delhi New Delhi : 110003 <BR>Tel: 91-011-24627552 <BR>Email: investorrelations@nucleussoftware.c <BR>Website: http://www.nucleussoftware.com

Who are the peers of the Nucleus Soft.?

Nucleus Soft.'s peers include Tanla Platforms, C.E. Info System, Moschip Tech., and others. Management risk varies from excellent to below average among peers, with Nucleus Soft. rated as good, and its 1-year return is -26.30%.

Peers: The peers of Nucleus Soft. are Tanla Platforms, C.E. Info System, Moschip Tech., Technvision Ven., Ramco Systems, Blue Cloud Soft., Subex, Unicommerce, Quick Heal Tech, and IRIS Regtech Sol.<BR><BR>Quality Snapshot: Excellent management risk is observed at C.E. Info System and Unicommerce, while Good management risk is found at Nucleus Soft. and Tanla Platforms. Average management risk is noted for Technvision Ven., Blue Cloud Soft., and Subex, while Below Average management risk is seen at Moschip Tech. and Ramco Systems. Growth is Excellent at Moschip Tech. and Unicommerce, while Average growth is found at Technvision Ven. and Blue Cloud Soft. Below Average growth is noted for Nucleus Soft., Tanla Platforms, C.E. Info System, Ramco Systems, and Quick Heal Tech. Excellent capital structure is observed at C.E. Info System, Tanla Platforms, Technvision Ven., and Nucleus Soft., while Good capital structure is found at Moschip Tech., Subex, and Quick Heal Tech. Average capital structure is noted for Blue Cloud Soft., while Below Average capital structure is seen at Ramco Systems.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Moschip Tech. at 26.97%, while Quick Heal Tech has the lowest at -52.52%. Nucleus Soft.'s 1-year return is -26.30%, which is better than Quick Heal Tech. but worse than Moschip Tech. Additionally, the six-month return is negative for Tanla Platforms, Ramco Systems, Blue Cloud Soft., and Quick Heal Tech.

How big is Nucleus Soft.?

As of 31st August, Nucleus Software Exports Ltd has a market capitalization of 1,947.00 Cr, with Net Sales of 868.74 Cr and a Net Profit of 105.41 Cr for the latest four quarters. Shareholder's Funds are 907.45 Cr and Total Assets are 1,266.13 Cr as of March 2026.

As of 31st August, Nucleus Software Exports Ltd has a market capitalization of 1,947.00 Cr, categorizing it as a Small Cap company.<BR><BR>For the latest four quarters, Nucleus Software reported Net Sales of 868.74 Cr and a Net Profit of 105.41 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, with Shareholder's Funds amounting to 907.45 Cr and Total Assets totaling 1,266.13 Cr.

Are Nucleus Software Exports Ltd latest results good or bad?

Nucleus Software Exports Ltd's latest results are concerning, showing a 30.91% decline in net profit and a drop in operating margins to 3.78%, the lowest in eight quarters, primarily due to rising employee costs. Overall, the financial health of the company appears to be under pressure, indicating significant operational challenges.

The latest results for Nucleus Software Exports Ltd are concerning and indicate a significant deterioration in performance. In Q1 FY27, the company reported a net profit of ₹23.87 crore, which is a decline of 30.91% quarter-on-quarter and 32.19% year-on-year. Net sales also fell to ₹210.43 crore, down 6.38% from the previous quarter and 3.35% from the same quarter last year. <BR><BR>Operating margins have collapsed to 3.78%, the lowest in eight quarters, down from 15.55% in the previous quarter. This sharp decline in profitability is primarily attributed to rising employee costs, which now constitute a significant portion of net sales, further squeezing margins.<BR><BR>The overall financial health of the company appears to be under pressure, with key metrics indicating operational challenges. The stock has reacted negatively, trading significantly below its 52-week high, and technical indicators suggest persistent weakness. Given these factors, the latest results can be characterized as bad, reflecting serious operational and financial challenges that the company needs to address.

Should I buy, sell or hold Nucleus Software Exports Ltd?

When is the next results date for Nucleus Software Exports Ltd?

The next results date for Nucleus Software Exports Ltd is 21 May 2026.

The next results date for Nucleus Software Exports Ltd is scheduled for 21 May 2026.

Is Nucleus Soft. technically bullish or bearish?

As of November 21, 2025, Nucleus Soft's technical trend has shifted to a moderate bearish stance, supported by bearish signals from the MACD, KST, and moving averages, despite mixed signals from the Dow Theory.

As of 21 November 2025, the technical trend for Nucleus Soft has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the weekly MACD and KST both showing bearish signals, along with daily moving averages confirming a bearish trend. Bollinger Bands are also indicating bearish conditions on both weekly and monthly time frames. The Dow Theory presents a mixed view with weekly mildly bearish and monthly mildly bullish signals, but overall, the prevailing indicators suggest a bearish outlook.

How has been the historical performance of Nucleus Soft.?

Nucleus Soft has shown steady growth in net sales, increasing from 484.03 Cr in Mar'19 to 832.25 Cr in Mar'25, despite fluctuations in profit margins and cash flow. Total assets also grew significantly, from 757.89 Cr in Mar'20 to 1,152.95 Cr in Mar'25.

Answer:<BR>The historical performance of Nucleus Soft shows a steady growth in net sales and profit over the years, with some fluctuations in margins and expenses.<BR><BR>Breakdown:<BR>Nucleus Soft's net sales have increased from 484.03 Cr in Mar'19 to 832.25 Cr in Mar'25, indicating a consistent upward trend. Total operating income followed a similar trajectory, reaching 832.25 Cr in Mar'25 from 484.03 Cr in Mar'19. The total expenditure, excluding depreciation, rose from 404.78 Cr in Mar'19 to 663.90 Cr in Mar'25, reflecting increased operational costs. Operating profit, excluding other income, peaked at 220.40 Cr in Mar'24 but fell to 168.35 Cr in Mar'25. Profit before tax also showed growth, reaching 219.05 Cr in Mar'25, although it was lower than the previous year's 255.80 Cr. Profit after tax reached 163.00 Cr in Mar'25, down from 191.60 Cr in Mar'24. The company's total assets grew from 757.89 Cr in Mar'20 to 1,152.95 Cr in Mar'25, while total liabilities increased from 404.78 Cr to 1,152.95 Cr in the same period. Cash flow from operating activities was 150.00 Cr in Mar'25, down from 222.00 Cr in Mar'24, but the closing cash and cash equivalents rose to 50.00 Cr in Mar'25 from 45.00 Cr in Mar'24. Overall, Nucleus Soft has demonstrated significant growth in sales and assets, despite some fluctuations in profit margins and cash flow.

Is Nucleus Soft. overvalued or undervalued?

As of November 10, 2025, Nucleus Software's valuation has improved to attractive, with a PE ratio of 16.48 and an EV to EBITDA of 13.93, indicating it is undervalued compared to peers like TCS and Infosys, and despite short-term underperformance, it has delivered a significant 156.85% return over the past three years.

As of 10 November 2025, the valuation grade for Nucleus Software has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE ratio of 16.48, an EV to EBITDA of 13.93, and a ROCE of 33.63%. <BR><BR>In comparison to its peers, TCS has a PE ratio of 21.77 and an EV to EBITDA of 8.55, while Infosys shows a PE of 22.37 and an EV to EBITDA of 5.4. These comparisons highlight that Nucleus Software's valuation is more favorable relative to its peers, suggesting potential for growth. Additionally, while the stock has underperformed the Sensex in the short term, its long-term performance over three years shows a significant return of 156.85%, reinforcing its attractiveness as an investment opportunity.

Who are the top shareholders of the Nucleus Soft.?

The top shareholder of Nucleus Soft is Karmayogi Holdings Private Ltd, with a 33.59% stake. Other notable shareholders include 53 Foreign Institutional Investors holding 4.83%, Barca Global Master Fund, Lp with 2.04%, and individual investors collectively owning 17.35%.

The top shareholders of Nucleus Soft include Karmayogi Holdings Private Ltd, which holds the largest stake at 33.59%. The company is primarily owned by its promoters, with no pledged promoter holdings. Additionally, there are 53 Foreign Institutional Investors (FIIs) collectively holding 4.83% of the shares, and two mutual fund schemes that account for 1.38%. The highest public shareholder is Barca Global Master Fund, Lp, with a 2.04% stake. Individual investors collectively hold 17.35% of the company.

What is the bonus history of the Nucleus Soft.?

Nucleus Software Exports Ltd issued a 1:1 bonus on August 3, 2007, with a record date of August 6, 2007, granting shareholders one additional share for each share held.

Nucleus Software Exports Ltd has a bonus history that includes a 1:1 bonus issue announced on August 3, 2007. The record date for this bonus was August 6, 2007. This means that shareholders received one additional share for every share they held as of the record date.

Has Nucleus Soft. declared dividend?

Yes, Nucleus Software Exports Ltd has declared a dividend of 125%, amounting to ₹12.5 per share, with an ex-date of July 5, 2024. The company has demonstrated strong total returns over various periods, particularly in the long term.

Nucleus Software Exports Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 125%<BR>- Amount per share: 12.5<BR>- Ex-date: 05 Jul 24<BR><BR>Dividend Yield: 1%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 6.26%, with no dividend return, resulting in a total return of 6.26%.<BR><BR>Over the past year, the price return was 4.66%, the dividend return was 1.01%, leading to a total return of 5.67%.<BR><BR>In the 2-year period, the price return was 0.81%, the dividend return was 2.12%, culminating in a total return of 2.93%.<BR><BR>For the last 3 years, the price return was an impressive 194.79%, with a dividend return of 7.95%, resulting in a total return of 202.74%.<BR><BR>Over the 4-year period, the price return was 111.98%, the dividend return was 6.05%, which gave a total return of 118.03%.<BR><BR>In the 5-year span, the price return was 393.98%, the dividend return was 14.10%, leading to a total return of 408.08%.<BR><BR>Overall, Nucleus Software Exports Ltd has declared a substantial dividend and has shown strong total returns across multiple periods, particularly in the longer term, indicating a positive performance trend for investors.